Evolent Health Stock Top Insiders
| EVH Stock | USD 3.90 -0.01 -0.26% |
Evolent Health's institutional ownership, insider transactions, and float profile are mapped. About 98.39% of Evolent Health's shares are held by institutions, with insiders holding 1.62%. Insider transaction patterns around earnings dates can reveal confidence or hedging behavior.
| Seth Blackley CEO Co-Founder, CEO & Director |
Evolent Health |
Management Team Effectiveness
EVH has Return on Asset of -0.13% indicating the asset base is not covering its cost of capital. Below breakeven, consistent with a loss-making period. Evolent Health also reports a return on shareholders' equity (ROE) of -66.54%, which means that it produced no profit with money invested by stockholders.Insider Trading Activities
Insider activity around Evolent Health matters because officers and directors often act on business changes before the market catches up. At small-cap scale, institutional coverage and secondary-market liquidity are typically well established. These records work best as context, not as standalone buy-or-sell signals.
Outstanding Bonds
Outstanding bonds linked to Evolent Health can tell investors a great deal about how the company finances itself beyond common equity markets. Used together with earnings and cash-flow analysis, the bond stack can reveal whether leverage is a manageable tool or a developing constraint.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Holders Distribution
Institutional ownership analysis for Evolent Health matters because banks, hedge funds, pension plans, and other professional participants influence price and liquidity more forcefully than smaller holders. One practical risk is that institutions can own millions of shares, so concentrated selling can pressure the stock quickly once sentiment changes.
Workforce Comparison
Evolent Health claims the number one ranking for number of employees among direct rivals. The total workforce of Health Care industry is currently estimated at about 13,403. Evolent Health totals roughly 4,200 in number of employees claiming about 31% of equities under Health Care sector.
EVH has Net Profit Margin of -28.0%. In the same way, it shows Net Operating Margin of -2.0%. Insider Trading History
Evolent Health's insider log provides a timeline of management conviction alongside earnings and guidance changes. Pattern analysis matters more than any single trade. The full record tells the real story.
Notable Stakeholders
Reviewing the stakeholders around Evolent Health reveals which people or institutions may influence direction, governance, and pressure on execution. This becomes more informative when seeking to understand not just ownership, but influence, incentives, and strategic pressure points.
| Seth Blackley | Co-Founder, CEO & Director | Profile | |
| Dan McCarthy | President | Profile | |
| Aammaad Shams | Chief Accounting Officer | Profile | |
| Mario Ramos | CFO | Profile | |
| Katie Cook | COO | Profile | |
| Robert Cruz | CTO | Profile | |
| Emily Rafferty | Executive Vice President of Customer Success | Profile | |
| John Johnson | Chief Strategy Officer | Profile | |
| Jonathan Weinberg | Chief Legal Officer, General Counsel & Secretary | Profile | |
| Jessica Somers | Sr Devel | Profile | |
| Jessica White | CIO | Profile |
Management Information & Data Sources
Evolent Health is a small-cap company in NYSE Composite. Board composition and governance structure frame oversight quality and strategic accountability. Strong governance practices tend to correlate with more disciplined capital allocation over time. CEO is Seth Blackley with 4,200 employees and 11 reported executives.
Evolent Health values are built from periodic company reporting and market reference feeds, with reporting definitions aligned before display. Insider and management fields are mapped from published filings and company disclosures.
Editorial review and methodology oversight provided by: Rifka Kats, Member of Macroaxis Editorial Board
Workforce Efficiency and Productivity
Manpower analysis for Evolent Health matters because revenue per employee and earnings per employee can reveal shifts in productivity and operating discipline. When applied, manpower metrics highlight whether growth is being supported by better productivity or by heavier staffing costs.
Evolent Health Manpower Efficiency
Return on Evolent Health Manpower
| Revenue Per Employee | 446.7K | |
| Revenue Per Executive | 170.6M | |
| Net Loss Per Employee | 138K | |
| Net Loss Per Executive | 52.7M | |
| Working Capital Per Employee | 28.8K | |
| Working Capital Per Executive | 11M |
Popular Tools for Evolent Health Stock analysis
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categoriesPortfolio AnywhereTrack or share privately all of your investments from the convenience of any deviceFundamental AnalysisView fundamental data based on most recent published financial statementsCorrelation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlatedPerformance AnalysisCheck effects of mean-variance optimization against your current asset allocationPortfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market riskPortfolio ProphetUse AI to generate optimal portfolios and find investment opportunitiesStocks DirectoryFind actively traded stocks across global marketsPair CorrelationCompare performance and examine fundamental relationship between any two equity instruments